COVID-19 (death) |
Patient characteristics |
Age [>=65 years vs. <65 years] |
Hazard ratio: 6.170 (3.260-11.670)
|
Wu
|
|
|
COVID-19 (death) |
Patient characteristics |
Gender [Male vs. Female] |
Hazard ratio: 0.560 (0.300-1.050)
|
Wu
|
|
|
COVID-19 (death) |
Symptoms |
Body temperature [Highest temperature >=39 ?C vs. Highest temperature <39 ?C] |
Hazard ratio: 0.410 (0.210-0.820)
|
Wu
|
|
|
COVID-19 (death) |
Comorbidities |
Hypertension [Present vs. Not present] |
Hazard ratio: 1.700 (0.920-3.140)
|
Wu
|
|
|
COVID-19 (death) |
Comorbidities |
Diabetes [Present vs. Not present] |
Hazard ratio: 1.580 (0.800-3.130)
|
Wu
|
|
|
COVID-19 (death) |
Laboratory Findings |
Neutrophils [Abnormal at admission vs. Normal] |
Hazard ratio: 1.080 (1.010-1.170)
|
Wu
|
|
|
COVID-19 (death) |
Laboratory Findings |
Lymphocytes [Abnormal at admission vs. Normal] |
Hazard ratio: 0.510 (0.220-1.170)
|
Wu
|
|
|
COVID-19 (death) |
Laboratory Findings |
CD3 [Abnormal at admission vs. Normal] |
Hazard ratio: 0.810 (0.590-1.110)
|
Wu
|
|
|
COVID-19 (death) |
Laboratory Findings |
CD4 [Abnormal at admission vs. Normal] |
Hazard ratio: 0.830 (0.510-1.350)
|
Wu
|
|
|
COVID-19 (death) |
Laboratory Findings |
CD8 [Abnormal at admission vs. Normal] |
Hazard ratio: 0.510 (0.240-1.090)
|
Wu
|
|
|
COVID-19 (death) |
Laboratory Findings |
Total bilirubin [Abnormal at admission vs. Normal] |
Hazard ratio: 1.070 (1.020-1.120)
|
Wu
|
|
|
COVID-19 (death) |
Laboratory Findings |
AST [Abnormal at admission vs. Normal] |
Hazard ratio: 0.990 (0.980-1.010)
|
Wu
|
|
|
COVID-19 (death) |
Laboratory Findings |
ALT [Abnormal at admission vs. Normal] |
Hazard ratio: 1.000 (0.980-1.010)
|
Wu
|
|
|
COVID-19 (death) |
Laboratory Findings |
Albumin [Abnormal at admission vs. Normal] |
Hazard ratio: 0.190 (0.070-0.490)
|
Wu
|
|
|
COVID-19 (death) |
Laboratory Findings |
Globulin [Abnormal at admission vs. Normal] |
Hazard ratio: 1.910 (1.010-3.610)
|
Wu
|
|
|
COVID-19 (death) |
Laboratory Findings |
Prealbumin [Abnormal at admission vs. Normal] |
Hazard ratio: 1.000 (0.990-1.001)
|
Wu
|
|
|
COVID-19 (death) |
Laboratory Findings |
Urea [Abnormal at admission vs. Normal] |
Hazard ratio: 1.130 (1.060-1.200)
|
Wu
|
|
|
COVID-19 (death) |
Laboratory Findings |
Creatinine [Abnormal at admission vs. Normal] |
Hazard ratio: 1.040 (0.970-1.110)
|
Wu
|
|
|
COVID-19 (death) |
Laboratory Findings |
Glucose [Abnormal at admission vs. Normal] |
Hazard ratio: 1.000 (0.920-1.080)
|
Wu
|
|
|
COVID-19 (death) |
Laboratory Findings |
CK-MB [Abnormal at admission vs. Normal] |
Hazard ratio: 0.990 (0.970-1.010)
|
Wu
|
|
|
COVID-19 (death) |
Laboratory Findings |
Cholinesterase [Abnormal at admission vs. Normal] |
Hazard ratio: 0.840 (0.730-0.970)
|
Wu
|
|
|
COVID-19 (death) |
Laboratory Findings |
Cystatin [Abnormal at admission vs. Normal] |
Hazard ratio: 1.800 (1.280-2.530)
|
Wu
|
|
|
COVID-19 (death) |
Laboratory Findings |
LDH [Abnormal at admission vs. Normal] |
Hazard ratio: 1.300 (1.110-1.520)
|
Wu
|
|
|
COVID-19 (death) |
Laboratory Findings |
a-HBDH [Abnormal at admission vs. Normal] |
Hazard ratio: 1.340 (1.130-1.600)
|
Wu
|
|
|
COVID-19 (death) |
Laboratory Findings |
LDL [Abnormal at admission vs. Normal] |
Hazard ratio: 0.840 (0.540-1.310)
|
Wu
|
|
|
COVID-19 (death) |
Laboratory Findings |
IL-6 [Abnormal at admission vs. Normal] |
Hazard ratio: 1.030 (1.010-1.050)
|
Wu
|
|
|
COVID-19 (death) |
Laboratory Findings |
ESR [Abnormal at admission vs. Normal] |
Hazard ratio: 1.010 (0.990-1.020)
|
Wu
|
|
|
COVID-19 (death) |
Laboratory Findings |
Serum ferritin [Abnormal at admission vs. Normal] |
Hazard ratio: 5.280 (0.720-38.480)
|
Wu
|
|
|
COVID-19 (death) |
Laboratory Findings |
PT [Abnormal at admission vs. Normal] |
Hazard ratio: 1.080 (0.840-1.380)
|
Wu
|
|
|
COVID-19 (death) |
Laboratory Findings |
APTT [Abnormal at admission vs. Normal] |
Hazard ratio: 0.960 (0.910-1.000)
|
Wu
|
|
|
COVID-19 (death) |
Laboratory Findings |
D-dimer [Abnormal at admission vs. Normal] |
Hazard ratio: 1.020 (1.010-1.040)
|
Wu
|
|
|
COVID-19 (death) |
Treatment |
Treatment for COVID-19 [Methylprednisolone administred vs. Not received] |
Hazard ratio: 1.020 (0.200-0.720)
|
Wu
|
|
|
COVID-19 (severe/fatal) |
Comorbidities |
Hypertension [Present vs. Not present] |
Hazard ratio: 1.820 (1.130-2.950)
|
Wu
|
|
|
COVID-19 (severe/fatal) |
Symptoms |
Body temperature [Highest temperature <39 ?C vs. Highest temperature >=39 ?C] |
Hazard ratio: 1.770 (1.110-2.840)
|
Wu
|
|
|
COVID-19 (severe/fatal) |
Patient characteristics |
Gender [Male vs. Female] |
Hazard ratio: 1.470 (0.920-2.360)
|
Wu
|
|
|
COVID-19 (severe/fatal) |
Patient characteristics |
Age [>=65 years vs. <65 years] |
Hazard ratio: 3.260 (2.080-5.110)
|
Wu
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Age [>=65 years vs. <65 years] |
Odds ratio: 81.200 (1.100-999.990)
§ |
Wu
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
CRP [Abnormal at admission vs. Normal] |
Odds ratio: 10.530 (1.220-34.700)
§ |
Liu
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Creatinine [Abnormal at admission vs. Normal] |
Odds ratio: 0.710 (0.020-1.350)
§ |
Liu
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Albumin [Abnormal at admission vs. Normal] |
Odds ratio: 7.350 (1.100-50.000)
§ |
Liu
|
|
|
COVID-19 (severe/critical) |
Symptoms |
Respiratory failure [Present at admission vs. Not present] |
Odds ratio: 8.770 (1.940-40.000)
§† |
Liu
|
|
|
COVID-19 (severe/critical) |
Symptoms |
Body temperature [Fever present vs. <37.3 ?C at admission] |
Odds ratio: 9.000 (1.040-78.150)
§ |
Liu
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Smoking [History of smoking vs. No history of smoking] |
Odds ratio: 14.290 (1.580-25.000)
§† |
Liu
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Age [>60 years vs. <=60 years] |
Odds ratio: 8.550 (1.630-44.860)
§ |
Liu
|
|
|
COVID-19 (death) |
Laboratory Findings |
D-dimer [Abnormal at admission vs. Normal] |
Odds ratio: 18.420 (2.640-128.550)
§† |
Zhou
|
|
|
COVID-19 (death) |
Complications |
Sequential Organ Failure Assessment (SOFA) score [1 unit increase vs. SOFA score: 0] |
Odds ratio: 5.650 (2.610-12.230)
§ |
Zhou
|
|
|
COVID-19 (death) |
Comorbidities |
Coronary heart disease [Present vs. Not present] |
Odds ratio: 2.140 (0.260-17.790)
§† |
Zhou
|
|
|
COVID-19 (death) |
Patient characteristics |
Age [1 year increase vs. Not applicable] |
Odds ratio: 1.100 (1.030-1.170)
§ |
Zhou
|
|
|
COVID-19 (death) |
Patient characteristics |
ABO blood group [0 blood group vs. Persons with other than 0 blood group] |
Odds ratio: 0.660 (0.480-0.910)
§† |
Zhao
|
|
|
COVID-19 (death) |
Patient characteristics |
ABO blood group [A blood group vs. Persons with other than A blood group] |
Odds ratio: 1.480 (1.110-1.970)
§† |
Zhao
|
|
|